Models of cardioprotection

Drug Discovery Today: Disease Models

Volumn 4, Issue 4, 2007, Pages 185-190

  Jovanović, Sofija ^a   Jovanović, Aleksandar ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CAUSE OF DEATH; DISABILITY; EXPERIMENTAL MODEL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MORBIDITY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

EID: 46949110203     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2007.06.002     Document Type: Review

References (34)

1. The World Health Organization (WHO) (2003) The World Health Report 2003.
2. Murray C.E., et al. Precoditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
3. Ytrehus K. The ischemic heart - experimental models. Pharmacol. Res. 42 (2000) 193-203
4. Ytrehus K. Models of myocardial ischaemia. Drug Discov. Today 3 (2006) 263-271
5. Conci E., et al. Mouse model of myocardial ischaemia/reperfusion. J. Kardiol. 13 (2006) 239-244
6. Marber M.S., et al. Ischemic preconditioning in isolated cells. Circ. Res. 86 (2000) 926-931
7. Diaz R.J., and Wilson G.J. Studying ischemic preconditioning in isolated cardiomyocyte models. Cardiovasc. Res. 70 (2006) 286-296
8. Claycomb W.C., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2979-2984
9. Hescheler J., et al. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ. Res. 69 (1991) 1476-1486
10. ATP channels in heart-derived H9c2 cells. J. Am. Coll. Cardiol. 40 (2002) 367-374
11. 2+ loading in single cardiomyocytes exposed to severe metabolic stress. Int. J. Mol. Med. 7 (2001) 639-643
12. Jovanović S., et al. High glucose protects single beating adult cardiomyocytes against hypoxia. Biochem. Biophys. Res. Commun. 341 (2006) 57-66
13. Du Q., et al. Overexpression of SUR2A generates a cardiac phenotype resistant to ischaemia. FASEB J. 20 (2006) 1131-1141
14. + channel subunits confer resistance towards chemical hypoxia-reoxygenation injury. Circulation 98 (1998) 1548-1555
15. + channels. J. Biol. Chem. 278 (2003) 31444-31455
16. Budas G.R., et al. 3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. FASEB J. 20 (2006) 2556-2558
17. + channels. J. Cell. Physiol. 210 (2007) 224-236
18. Gomez L.A., et al. Use of the MTT assay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. J. Mol. Cell. Cardiol. 29 (1997) 1255-1266
19. Zingarelli B., et al. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res. 83 (1998) 85-94
20. Fishbein M.C., et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am. Heart J. 101 (1981) 593-600
21. Rajappa M., and Sharma A. Biomarkers of cardiac injury: an update. Angiology 56 (2005) 677-691
22. Gibbons R.J., et al. The quantification of infarct size. J. Am. Coll. Cardiol. 44 (2004) 1533-1542
23. Shiomi M., et al. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1239-1244
24. Braun A., et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ. Res. 90 (2002) 270-276
25. O'Brien P.J. Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker. Expert Rev. Mol. Diagn. 6 (2006) 685-702
26. Scherrer-Crosbie M., et al. Three-dimension echocardiographic assessment of left ventricular wall motion abnormalities in mouse myocardial infarction. J. Am. Soc. Echocardiogr. 12 (1999) 834-840
27. Huttemann E. Transoesophageal echocardiography in critical care. Minerva Anestesiol. 72 (2006) 891-913
28. Patel R.A., and Beller G.A. Prognostic role of single-photon emission computed tomography (SPECT) imaging in myocardial viability. Curr. Opin. Cardiol. 21 (2006) 457-463
29. Fernandes V.R., et al. Aterosclerosis imaging and heart failure. Heart Fail. Rev. 11 (2006) 279-288
30. Kramer K., et al. The use of telemetry in small laboratory animals. Contemp. Top. Lab. Anim. Sci. 40 (2001) 8-16
31. Salem J.E., et al. Step and ramp induction of myocardial ischaemia: comparison of in vivo and in silico results. J. Physiol. Pharmacol. 55 (2004) 519-536
32. Herz S.L., et al. Parameterization of left ventricle wall motion for detection of regional ischemia. Ann. Biomed. Eng. 33 (2005) 912-919
33. +: insights from in silico studies. J. Physiol. 569 (2005) 925-937
34. Kloner R.A., and Rezkalla S.H. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc. Res. 70 (2006) 297-307